Genetic variations associated with postoperative recurrence in stage I non-small cell lung cancer

Clinical Cancer Research

Volumn 20, Issue 12, 2014, Pages 3272-3279

  Yoon, Kyong Ah ^a   Jung, Mee Kyung ^a   Lee, Dong Hoon ^a   Bae, Kieun ^a   Joo, Jung Nam ^a   Lee, Geon Kook ^a   Lee, Hyun Sung ^a   Lee, Jin Soo ^a  

^a National Cancer Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CHROMOSOMAL LOCALIZATION; CHROMOSOME 4Q; EARLY CANCER; FEMALE; GENETIC ASSOCIATION; GENETIC IDENTIFICATION; GENETIC MARKER; GENETIC RISK; GENETIC SCREENING; GENETIC VARIABILITY; HAPLOTYPE; HISTOPATHOLOGY; HUMAN; KOREAN (PEOPLE); LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT OUTCOME; ADENOCARCINOMA; CHROMOSOME 4; CHROMOSOME MAP; FOLLOW UP; GENETIC PREDISPOSITION; GENETICS; LUNG TUMOR; MIDDLE AGED; NON SMALL CELL LUNG CANCER; PATHOLOGY; PROGNOSIS; SQUAMOUS CELL CARCINOMA; TUMOR RECURRENCE;

TUMOR MARKER;

ADENOCARCINOMA; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 4; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HAPLOTYPES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; POLYMORPHISM, SINGLE NUCLEOTIDE; POSTOPERATIVE PERIOD; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84902655051     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-13-2835     Document Type: Article

References (30)

1. Jee SH, Kim IS, Suh I, Shin D, Appel LJ. Projected mortality from lung cancer in South Korea, 1980-2004. Int J Epidemiol 1998;27:365-9. (Pubitemid 28336960)
2. Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 2006;24:2137-50. (Pubitemid 46655601)
3. Marugame T, Hirabayashi Y. Comparison of time trends in lung cancer mortality (1990-2006) in the world, from the WHO Mortality Database. Jpn J Clin Oncol 2009;39:696-7.
4. Choi JH, Chung HC, Yoo NC, Lee HR, Lee KH, Choi W, et al. Changing trends in histologic types of lung cancer during the last decade (1981-1990) in Korea: a hospital-based study. Lung Cancer (Amsterdam, Netherlands) 1994;10:287-96. (Pubitemid 24115519)
5. Kim YC, Kwon YS,OhIJ, Kim KS, Kim SY, Ryu JS, et al. National survey of lung cancer in Korea, 2005. J Lung Cancer 2007;6:67-73.
6. Goldstraw P, Crowley J, Chansky K, Giroux DJ, Groome PA, Rami-Porta R, et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol 2007;2:706-14. (Pubitemid 47357522)
7. Groome PA, Bolejack V, Crowley JJ, Kennedy C, Krasnik M, Sobin LH, et al. The IASLC Lung Cancer Staging Project: validation of the proposals for revision of the T, N, and M descriptors and consequent stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol 2007;2:694-705. (Pubitemid 47357521)
8. Hung JJ, Hsu WH, HsiehCC, Huang BS, Huang MH, Liu JS, et al. Post-recurrence survival in completely resected stage I non-small cell lung cancer with local recurrence. Thorax 2009;64:192-6.
9. Sugimura H, Nichols FC, Yang P, Allen MS, Cassivi SD, Deschamps C, et al. Survival after recurrent nonsmall-cell lung cancer after complete pulmonary resection. Ann Thorac Surg 2007;83:409-17; discussioin 417-8.
10. Hu L, Wu C, Zhao X, Heist R, Su L, Zhao Y, et al. Genome-wide association study of prognosis in advanced non-small cell lung cancer patients receiving platinum-based chemotherapy. Clin Cancer Res 2012;18:5507-14.
11. Azzato EM, Pharoah PD, Harrington P, Easton DF, Greenberg D, Caporaso NE, et al. A genome-wide association study of prognosis in breast cancer. Cancer Epidemiol Biomarkers Prev 2010;19:1140-3.
12. Muller-Tidow C, Diederichs S, Thomas M, Serve H. Genome-wide screening for prognosis-predicting genes in early-stage non-small-cell lung cancer. Lung Cancer (Amsterdam, Netherlands) 2004;45 Suppl 2:S145-50. (Pubitemid 39488184)
13. Innocenti F, Owzar K, Cox NL, Evans P, Kubo M, Zembutsu H, et al. A genome-wide association study of overall survival in pancreatic cancer patients treated with gemcitabine in CALGB 80303. Clin Cancer Res 2012;18:577-84.
14. Huang YT, Heist RS, Chirieac LR, Lin X, Skaug V, Zienolddiny S, et al. Genome-wide analysis of survival in early-stage non-small-cell lung cancer. J Clin Oncol 2009;27:2660-7.
15. Wu X, Ye Y, Rosell R, Amos CI, Stewart DJ, Hildebrandt MAT, et al. Genome-wide association study of survival in non-small cell lung cancer patients receiving platinum-based chemotherapy. J Natl Cancer Inst 2011;103:817-25.
16. Sato Y, Yamamoto N, Kunitoh H, Ohe Y, Minami H, Laird NM, et al. Genome-wide association study on overall survival of advanced nonsmall cell lung cancer patients treated with carboplatin and paclitaxel. J Thorac Oncol 2011;6:132-8.
17. Schemper M, Smith TL. A note on quantifying follow-up in studies of failure time. Control Clin Trials 1996;17:343-6. (Pubitemid 26342716)
18. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007;81:559-75. (Pubitemid 47330214)
19. Clarke GM, Anderson CA, Pettersson FH, Cardon LR, Morris AP, Zondervan KT. Basic statistical analysis in genetic case-control studies. Nat Protoc 2011;6:121-33.
20. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21:263-5. (Pubitemid 40202029)
21. Stephens M, Donnelly P. A comparison of Bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 2003;73:1162-9. (Pubitemid 37414228)
22. Storey JD, Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci U S A 2003;100:9440-5. (Pubitemid 37033947)
23. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B (Methodological) 1995;57:289-300.
24. Du Z, Fei T, Verhaak RG, Su Z, Zhang Y, Brown M, et al. Integrative genomic analyses reveal clinically relevant long noncoding RNAs in human cancer. Nat Struct Mol Biol 2013;20:908-13.
25. Zack TI, Schumacher SE, Carter SL, Cherniack AD, Saksena G, Tabak B, et al. Pan-cancer patterns of somatic copy number alteration. Nat Genet 2013;45:1134-40.
26. Letouze E, Rosati R, Komechen H, Doghman M, Marisa L, Fluck C, et al. SNP array pro filing of childhood adrenocortical tumors reveals distinct pathways of tumorigenesis and highlights candidate driver genes. J Clin Endocrinol Metab 2012;97:E1284-93.
27. Douglas EJ, Fiegler H, Rowan A, Halford S, Bicknell DC, Bodmer W, et al. Array comparative genomic hybridization analysis of colorectal cancer cell lines and primary carcinomas. Cancer Res 2004;64:4817-25. (Pubitemid 38924525)
28. Kohno T, Kawanishi M, Inazawa J, Yokota J. Identification of CpG islands hypermethylated in human lung cancer by the arbitrarily primed-PCR method. Hum Genet 1998;102:258-64. (Pubitemid 28185212)
29. Takata T, Tanaka F,Yamada T, Yanagihara K, Otake Y, Kawano Y, et al. Clinical signi ficance of caspase-3 expression in pathologic-stage I, nonsmall-cell lung cancer. Int J Cancer 2001;96 Suppl:54-60.
30. Ogawa E, Takenaka K, Yanagihara K, Kurozumi M, Manabe T, Wada H, et al.Clinical significance of VEGF-Cstatus in tumour cells and stromal macrophages in non-small cell lung cancer patients. Br J Cancer 2004;91:498-503. (Pubitemid 39093569)